Zomedica Corp. (ZOM)
| Market Cap | 364.72M |
| Revenue (ttm) | 7.87M |
| Net Income (ttm) | -18.23M |
| Shares Out | 979.90M |
| EPS (ttm) | -0.02 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 14,299,265 |
| Open | 0.366 |
| Previous Close | 0.355 |
| Day's Range | 0.355 - 0.377 |
| 52-Week Range | 0.175 - 0.800 |
| Beta | 0.63 |
| Analysts | Buy |
| Price Target | n/a |
| Earnings Date | Aug 15, 2022 |
About ZOM
Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment of various musculoskeletal issues, such as broken bones, tendonitis, and torn ligaments in horses and small animals. It has collaboration agreements with Celsee, Inc. for the development and commerciali... [Read more...]
Financial Performance
Financial StatementsAnalyst Forecast
No stock price forecast available yet.
News
Zomedica Corp. to Present at Investor Summit Group's Q3 Virtual Conference
Ann Arbor, Michigan--(Newsfile Corp. - August 9, 2022) - Zomedica Corp. (NYSE American: ZOM) today announced that Larry Heaton, CEO, will be attending the Q3 Virtual Investor Summit. During the presenta...
Zomedica Acquires Assets of Leading tPEM(TM) Company Assisi Animal Health
ANN ARBOR, MI / ACCESSWIRE / July 18, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion anim...
Zomedica Announces New Global Manufacturing & Distribution Center
ANN ARBOR, MI / ACCESSWIRE / July 7, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion anima...
ZOM Stock Pops 5% as Zomedica Acquires Revo Squared
ZOM stock is on the rise as Zomedica acquires crucial technology that will provide veterinarians with enhanced diagnostic imaging quality. The post ZOM Stock Pops 5% as Zomedica Acquires Revo Squared ap...
Zomedica Finalizes Acquisition of Veterinary Imaging Company Revo Squared
ANN ARBOR, MI / ACCESSWIRE / July 6, 2022 / Zomedica Corp. (NYSE American:ZOM) ('Zomedica' or the 'Company'), a veterinary health company offering diagnostic and therapeutic products for companion anima...
Zomedica Announces Designation of PulseVet(R) System as the Official Shock Wave Therapy Supplier of the United States...
ANN ARBOR, MI / ACCESSWIRE / June 28, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for equine and com...
Zomedica to Participate in Panel Discussion at Animal Health Investment Forum
ANN ARBOR, MI / ACCESSWIRE / June 21, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion anim...
Zomedica to Acquire Assets of Innovative Veterinary Imaging Company Revo Squared
ANN ARBOR, MI / ACCESSWIRE / June 15, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion anim...
Zomedica to Investigate Shock Wave Therapy of Exercised Induced Pulmonary Hemorrhage in Horses
ANN ARBOR, MI / ACCESSWIRE / June 13, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion anim...
Zomedica to Present at JMP Securities Life Sciences Conference
ANN ARBOR, MI / ACCESSWIRE / June 8, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for comp...
Karen DeHaan-Fullerton Joins Zomedica as General Counsel and Corporate Secretary
ANN ARBOR, MI / ACCESSWIRE / June 2, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for comp...
Zomedica Enters Into Strategic Investment and Potential Collaboration for VetGuardian Monitoring Product Line
ANN ARBOR, MI / ACCESSWIRE / May 19, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion anima...
Traders News Source Interviews Larry Heaton, CEO of Zomedica Corp.
NEW YORK, NY / ACCESSWIRE / May 18, 2022 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid cap publicly traded companies recently issued a n...
Zomedica CEO Interview with Wall Street Analyzer Discusses First Quarter 2022 Earnings and Future Plans
ANN ARBOR, MI / ACCESSWIRE / May 16, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for comp...
Why Zomedica Shares Are Falling Today
Zomedica Corp (NASDAQ: ZOM) shares are trading lower by 4.99% at $0.20. The company reported first-quarter earnings results during Tuesday's after-hours session.
Zomedica Announces First Quarter 2022 Revenues of $3.8 Million; 74% Gross Margin & $192.3 Million in Cash; Revenue up...
ANN ARBOR, MI / ACCESSWIRE / May 10, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for comp...
Zomedica(R) Supports Feline Animal Health With American Association of Feline Practitioners' Sponsorship
ANN ARBOR, MI / ACCESSWIRE / May 4, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion animal...
Zomedica to Present at H.C. Wainwright Global Investment Conference
ANN ARBOR, MI / ACCESSWIRE / April 27, 2022 / Zomedica Corp. (NYSE American:ZOM), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, announced...
Zomedica's Announces Designation of Pulsevet System as the Official Shock Wave Therapy of the American Quarter Horse ...
ANN ARBOR, MI / ACCESSWIRE / April 13, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion ani...
Zomedica Announces Launch of eACTH Assay for Truforma(R) Platform
ANN ARBOR, MI / ACCESSWIRE / April 4, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion anim...
2 Meme Stocks Investors Should Avoid at All Costs
These stocks are full of risk and losses are likely to mount in the future.
Dogs Win, Investors Lose With Zomedica
Zomedica said last year that Truforma would revolutionize veterinary care with radio waves. Now it would rather talk about PulseVet, which it bought in October The post Dogs Win, Investors Lose With Zom...
It's Going to Take a Lot to Get Zomedica Stock Out of the Doghouse
ZOM stockholders are likely to grow increasingly frustrated with management's misplaced optimism and the lack of Truforma sales. The post It's Going to Take a Lot to Get Zomedica Stock Out of the Doghou...
Will the PulseVet Acquisition Continue to Deliver Sales for Zomedica?
Zomedica Corp. (NYSEAMERICAN:ZOM) finally has a catalyst that could be a game-changer. It has reported $4.1 million in revenue for full-year 2021.
Zomedica Corporation Reports 2021 Fourth Quarter & Full Year Results
ANN ARBOR, MI / ACCESSWIRE / March 1, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion anim...